Eli Lilly Wins in LPG-1 Market Over Novo Nordisk, Earnings Show
The Eli Lilly and Novo Nordisk logos. Mike Blake | Little Tom | Reuters It's the story of two drugmakers…
Biotechnology and pharmaceuticals
Pfizer's monthly anti-obesity shot shows promise in trial
Smith Collection | Stock Photos | fake images Pfizer on Tuesday said its experimental anti-obesity drug, which it acquired through…
Pfizer (PFE) earnings in the fourth quarter of 2025
Albert Bourla, CEO of Pfizer, speaking at Squawk on the Street at the World Economic Forum in Davos, Switzerland, on…
Eli Lilly CEO David Ricks Discusses Medicare Coverage of Obesity Pills
Eli Lilly Chief Executive Dave Ricks said Friday that upcoming Medicare coverage of obesity drugs could be a major catalyst…
Eli Lilly plans $3.5 billion plant in Pennsylvania for obesity drugs
Eli Lilly Chairman and CEO Dave Ricks speaks during a news conference in Houston, Sept. 23, 2025. Antranik Tavitian |…
15 drugs added to Medicare price negotiations
Boxes of the drug Trulicity, manufactured by Eli Lilly and Company, sit on a pharmacy counter in Provo, Utah, on…
Danaher Stock Fails to Rise on Strong Earnings, Leaving Us to Wonder What's Next
Danaher shares fell Wednesday as Wall Street failed to give the supplier of tools and equipment to drugmakers and hospitals…
UnitedHealth Group (UNH) Earnings in Q4 2025
UnitedHealth Group Inc. signs on the floor of the New York Stock Exchange (NYSE) in New York, U.S., on Wednesday,…
Structure Therapeutics CEO talks obesity pill and more
Ray Stevens, CEO of Structure Therapeutics Inc., during a Bloomberg Television interview at the JPMorgan Healthcare Conference in San Francisco,…
Another Alliance Between Healthcare and AI Indicates Why Pharma Stocks Could Make a Comeback
Bristol Myers Squibb and Microsoft's new partnership aimed at accelerating the early detection of lung cancer marks the latest way…